Dr. Rellahan is a Team Leader in the Division of Monoclonal Antibodies (DMA) in the Office of Biotechnology Products, Office of Pharmaceutical Sciences, CDER/FDA. Dr. Rellahan acts as an expert in the division in relation to issues related to the function and potential activities of immunomodulatory antibodies. Prior to joining the FDA in 1995, Dr. Rellahan was a post-doctoral fellow at the National Institutes of Health and a National Research Council Fellow in the Division of Cytokine Biology, CBER/FDA. Dr. Rellahan earned her Ph.D. in Immunology from the University of Connecticut Health Science Center in 1988 and an M.S. in Cell Biology from the University of Cincinnati in 1984.